Targeting complement C3a receptor resolves mitochondrial hyperfusion and subretinal microglial activation in progranulin-deficient frontotemporal dementia.
Li Xuan TanFrederike Cosima OertelAn ChengYann CobigoAzeen KeihaniDaniel J BennettAhmed AbdelhakShivany Condor MontesMakenna ChapmanRobert Y ChenChristian CordanoMichael Emmerson WardKaitlin CasalettoJoel H KramerHoward J RosenAdam BoxerBruce L MillerAri J GreenFanny M ElahiAparna LakkarajuPublished in: bioRxiv : the preprint server for biology (2024)
Mutations in progranulin ( GRN ) cause frontotemporal dementia ( GRN -FTD) due to deficiency of the pleiotropic protein progranulin. GRN -FTD exhibits diverse pathologies including lysosome dysfunction, lipofuscinosis, microgliosis, and neuroinflammation. Yet, how progranulin loss causes disease remains unresolved. Here, we report that non-invasive retinal imaging of GRN -FTD patients revealed deficits in photoreceptors and the retinal pigment epithelium (RPE) that correlate with cognitive decline. Likewise, Grn -/- mice exhibit early RPE dysfunction, microglial activation, and subsequent photoreceptor loss. Super-resolution live imaging and transcriptomic analyses identified RPE mitochondria as an early driver of retinal dysfunction. Loss of mitochondrial fission protein 1 (MTFP1) in Grn -/- RPE causes mitochondrial hyperfusion and bioenergetic defects, leading to NF-kB-mediated activation of complement C3a-C3a receptor signaling, which drives further mitochondrial hyperfusion and retinal inflammation. C3aR antagonism restores RPE mitochondrial integrity and limits subretinal microglial activation. Our study identifies a previously unrecognized mechanism by which progranulin modulates mitochondrial integrity and complement-mediated neuroinflammation.
Keyphrases
- oxidative stress
- lps induced
- cognitive decline
- lipopolysaccharide induced
- inflammatory response
- optical coherence tomography
- traumatic brain injury
- diabetic retinopathy
- high resolution
- mild cognitive impairment
- neuropathic pain
- end stage renal disease
- gene expression
- prognostic factors
- single cell
- type diabetes
- skeletal muscle
- genome wide
- cancer therapy
- reactive oxygen species
- cell death
- drug delivery
- cerebral ischemia
- brain injury
- toll like receptor
- high fat diet induced
- metabolic syndrome
- patient reported outcomes
- pi k akt
- fluorescent probe
- subarachnoid hemorrhage